FOLLOW US

  • facebook
  • twitter
Fri

March 20, 2026

AstraZeneca China Obesity Drug Deal

America January 30, 2026

AstraZeneca China Obesity Drug Deal Worth Up to $18.5B

Biotechnology powerhouse AstraZeneca has inked a landmark licensing agreement with China’s CSPC Pharmaceutical Group Ltd., potentially worth $18.5 billion, aimed…

By Rihem Akkouche

Clearside Biomedical filed for Chapter 11

America November 24, 2025

Clearside Biomedical Filed for Chapter 11

Clearside Biomedical, a clinical-stage company specializing in eye-disease treatments, has filed for Chapter 11 bankruptcy in Delaware, launching a high-stakes…

By Rihem Akkouche

Bristol Myers' $1.5B Orbital Buy

America October 11, 2025

Bristol Myers’ $1.5B Orbital Buy Expands RNA Therapy Frontier in Autoimmune Diseases

In a bold leap into the next era of medical innovation, Bristol Myers Squibb announced Friday it will acquire Orbital…

By Rihem Akkouche

Halozyme to buy Elektrofi

America October 1, 2025

Halozyme to Buy Elektrofi in $900M Biotech Deal

Biopharmaceutical heavyweight Halozyme Therapeutics Inc. announced Wednesday it will acquire fellow biotech innovator Elektrofi Inc. in a deal valued at…

By Rihem Akkouche

ProPhase filed for Chapter 11

America September 22, 2025

ProPhase Filed for Chapter 11 as $13M Liabilities Collide With Crypto Ambitions

In a dramatic turn, ProPhase Labs Inc. placed three of its affiliates into Chapter 11 bankruptcy protection Monday in New…

By Rihem Akkouche

CSL to acquire VarmX

America September 16, 2025

CSL to Acquire VarmX in $2.2B Biotech Breakthrough Deal

In a high-stakes move that could reshape emergency medicine, global biotech giant CSL has struck an exclusive option agreement to…

By Rihem Akkouche

Novartis, Monte Rosa $5.7B Deal

America September 15, 2025

Novartis, Monte Rosa $5.7B Deal Targets Immune Diseases

In a bold wager on next-generation drug discovery, Novartis, Monte Rosa $5.7B Deal is set to reshape the landscape of…

By Rihem Akkouche

Novartis To Acquire Tourmaline Bio

America September 9, 2025

Novartis To Acquire Tourmaline Bio in $1.4B Deal to Boost Heart Drug Pipeline

Novartis AG said Tuesday it has agreed to acquire Tourmaline Bio Inc. in a $1.4 billion all-cash deal, a bold…

By Rihem Akkouche

AbbVie to Acquire Gilgamesh's Bretisilocin

America August 25, 2025

AbbVie to Acquire Gilgamesh’s Bretisilocin in $1.2B Psychedelic Bet

AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…

By Rihem Akkouche

Sanofi completes acquisition of Blueprint

America July 18, 2025

Sanofi Completes Acquisition of Blueprint Medicines

In a blockbuster pharma merger that shook the global biotech sector, Sanofi announced Friday it has officially completed its acquisition…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter